Elsevier

Genomics

Volume 58, Issue 1, 15 May 1999, Pages 34-40
Genomics

Regular Article
Linkage Analysis Narrows the Critical Region for Oculodentodigital Dysplasia to Chromosome 6q22–q23

https://doi.org/10.1006/geno.1999.5814Get rights and content

Abstract

Oculodentodigital dysplasia (ODDD) is an autosomal dominant condition with high penetrance and variable expressivity. The anomalies of the craniofacial region, eyes, teeth, and limbs indicate abnormal morphogenesis during early fetal development. Neurologic abnormalities occur later in life and appear to be secondary to white matter degeneration and basal ganglia changes. In familial cases, the dysmorphic and/or neurodegenerative components of the phenotype can be more severe and/or present at a younger age in subsequent generations, suggesting genetic anticipation. These clinical features suggest that the ODDD gene is pleiotropic with important functions throughout pre- and postnatal development. We have performed two-point linkage analysis with seven ODDD families and 19 microsatellite markers on chromosome 6q spanning a genetic distance of approximately 11 cM in males and 20 cM in females. We have refined the location of the ODDD gene between DNA markers D6S266/D6S261 (centromeric) and D6S1639 (telomeric), an interval of 1.01 (male) to 2.87 (female) cM. The strongest linkage was to DNA marker D6S433 (Zmax= 8.96, θmax= 0.001). Families show significant linkage to chromosome 6q22–q23 and no evidence for genetic heterogeneity.

References (51)

  • R.J. Gorlin et al.

    Oculodentodigital dysplasia

    J. Pediatr.

    (1963)
  • K.L. Jones et al.

    Older paternal age and fresh gene mutation: Data on additional disorders

    J. Pediatr.

    (1975)
  • H.S. Sugar et al.

    The oculo-dento-digital dysplasia syndrome

    Am. J. Ophthalmol.

    (1966)
  • G.A. Zach

    Oculodento-osseus dysplasia syndrome

    Oral Surg.

    (1975)
  • D. Audry et al.

    Manifestations neurologiques de la dysplasie oculo-dento-osseuse

    Rev. Otoneuroophthalmol.

    (1981)
  • A. Barnard et al.

    Intracranial calcification in oculodento-osseous dysplasia

    S. Afr. Med. J.

    (1981)
  • C. Battisti et al.

    Oculo-dento-digital syndrome (Gorlin's syndrome): Clinical and genetic report of a new family

    Acta Neurol.

    (1992)
  • P. Beighton et al.

    Oculodento-osseous dysplasia: Heterogeneity or variable expression?

    Clin. Genet.

    (1979)
  • L.A. Brueton et al.

    Oculodentodigital dysplasia and type III syndactyly: Separate genetic entities or disease spectrum?

    J. Med. Genet.

    (1990)
  • E.E. Castilla et al.

    Syndactyly: Frequency of specific types

    Am. J. Med. Genet.

    (1980)
  • A.T. Collete

    A case of syndactylism of the ring and little finger

    Am. J. Med. Genet.

    (1954)
  • R.W. Cottingham et al.

    Faster sequential genetic linkage computations

    Am. J. Hum. Genet.

    (1993)
  • D.R. Cox et al.

    Neurologic abnormalities in oculodentodigital dysplasia. A new finding

    Clin. Res.

    (1978)
  • R.H. Don et al.

    “Touchdown” PCR to circumvent spurious priming during gene amplification

    Nucleic Acids Res.

    (1991)
  • J. Dudgeon et al.

    Oculo-dento-digital dysplasia

    Trans. Ophthal. Soc. UK

    (1974)
  • F.D. Gillespie

    A hereditary syndrome: Dysplasia oculodentodigitalis

    Arch. Ophthalmol.

    (1964)
  • A. Gladwin et al.

    Localization of a gene for oculodentodigital syndrome to human chromosome 6q22–q24

    Hum. Mol. Genet.

    (1997)
  • R.E. Grubbs et al.

    Central nervous system abnormalities in oculodentodigital dysplasia syndrome

    Am. J. Med. Genet.

    (1994)
  • J. Guizar-Vazquez et al.

    Oculodentodigital dysplasia

    Rev. Invest. Clin.

    (1975)
  • D.H. Gutmann et al.

    Oculodentodigital dysplasia syndrome associated with abnormal cerebral white matter

    Am. J. Med. Genet.

    (1991)
  • O. Johnston et al.

    Syndactyly of the ring and little finger

    Am. J. Hum. Genet.

    (1954)
  • G.F. Judisch et al.

    Oculodentodigital dysplasia. Four new reports and a literature review

    Arch. Ophthalmol.

    (1979)
  • S. Kang et al.

    GLI3 frameshift mutations cause autosomal dominant Pallister–Hall syndrome

    Nat. Genet.

    (1997)
  • G.M. Lathrop et al.

    Easy calculations of lod scores and genetic risks on small computers

    Am. J. Hum. Genet.

    (1984)
  • J.M. Littlewood et al.

    The Holmes–Adie syndrome in a boy with acute juvenile rheumatism and bilateral syndactyly

    Arch. Dis. Child.

    (1963)
  • Cited by (32)

    • Syndromic and non-syndromic disease-linked Cx43 mutations

      2014, FEBS Letters
      Citation Excerpt :

      ODDD is primarily an autosomal-dominant human disorder where patients display symptoms of congenital craniofacial deformities, anomalies of the teeth and eyes and limb deformities [21–23]. Digital malformations include syndactyly involving the third, fourth and fifth fingers and camptodactyly of the second to fourth toe [21–23]. Most ODDD patients also have mandibular overgrowth, abnormal dentition, enamel hypoplasia and early tooth loss [19].

    • Connexin Mutations in Pelizaeus-Merzbacher-Like Disease, Oculodentodigital Dysplasia and Related Diseases

      2012, Gap Junctions in the Brain: Physiological and Pathological Roles
    • Gap junctions in inherited human disorders of the central nervous system

      2012, Biochimica et Biophysica Acta - Biomembranes
    • Novel GJA1 mutations in patients with oculo-dento-digital dysplasia (ODDD)

      2005, European Journal of Medical Genetics
      Citation Excerpt :

      Occasionally mild mental retardation is noticed and diffuse bilateral abnormalities in the white matter may be present on brain magnetic resonance studies. The ODDD locus resides on chromosome 6q22-q24 [1,6] and recently Paznekas et al. [22] reported that ODDD is caused by mutations in GJA1. This gene encodes the gap junction protein alpha 1 (GJA1 or connexin 43).

    View all citing articles on Scopus
    *

    These authors contributed equally to this study.

    To whom correspondence may be addressed at Institute of Genetic Medicine, CMSC 1004, 600 North Wolfe St., Baltimore, MD 21287-3914. Telephone: (410) 955-4160. Fax: (410) 955-0484. E-mail:[email protected].

    To whom correspondence may be addressed at Department of Neurology, Given B-211, College of Medicine, University of Vermont, Burlington, VT 05405-0068. Telephone: (802) 656-1480. Fax: (802) 656-5844. E-mail:[email protected].

    View full text